Efficacy of Mepolizumab for the Treatment of Eosinophilic Cystitis: A Report of 2 Cases.

Autor: Trefond L; Service de Médecine Interne, CHU Gabriel Montpied, Clermont- Ferrand, France.; Université Clermont Auvergne, Inserm U1071, M2iSH, USCINRA 1382, Clermont-Ferrand, France., Guy L; Service d'Urologie, CHU Gabriel Montpied, Clermont-Ferrand, France., Darcha C; Service d'Anatomopathologie, CHU Estaing, Clermont Ferrand, France., Gallon A; Service de Radiologie, CHU Gabriel Montpied, Clermont- Ferrand, France., Thomas-Monier R; Service de Radiologie, CHU Gabriel Montpied, Clermont- Ferrand, France., Berdugo K; National Reference Center for Hypereosinophilic Syndromes, CEREO, Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris, Department of Internal Medicine, Ambroise Paré Hospital, Boulogne-Billancourt, France., Smets P; Service de Médecine Interne, CHU Gabriel Montpied, Clermont- Ferrand, France., Olagne L; Service de Médecine Interne, CHU Gabriel Montpied, Clermont- Ferrand, France., Stievenart J; Service de Médecine Interne, CHU Gabriel Montpied, Clermont- Ferrand, France., Fayard D; Service de Médecine Interne, CHU Gabriel Montpied, Clermont- Ferrand, France., Cathebras P; Service de Médecine Interne, CHU de Saint-Étienne, SaintÉtienne, France., Aumaitre O; Service de Médecine Interne, CHU Gabriel Montpied, Clermont- Ferrand, France.; Université Clermont Auvergne, Inserm U1071, M2iSH, USCINRA 1382, Clermont-Ferrand, France., Boyer L; Service de Radiologie, CHU Gabriel Montpied, Clermont- Ferrand, France., Andre M; Service de Médecine Interne, CHU Gabriel Montpied, Clermont- Ferrand, France.; Université Clermont Auvergne, Inserm U1071, M2iSH, USCINRA 1382, Clermont-Ferrand, France., Kahn JE; National Reference Center for Hypereosinophilic Syndromes, CEREO, Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris, Department of Internal Medicine, Ambroise Paré Hospital, Boulogne-Billancourt, France.
Jazyk: angličtina
Zdroj: Journal of investigational allergology & clinical immunology [J Investig Allergol Clin Immunol] 2024 Jun 17; Vol. 34 (3), pp. 202-204. Date of Electronic Publication: 2023 Oct 18.
DOI: 10.18176/jiaci.0954
Databáze: MEDLINE